4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-24-099481
Chief Scientific Officer sold 16,496 shares at $2.96 ($48,883)
- Chief Scientific Officer acquired 16,496 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SCIASCIA THOMAS · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-19 | Exercise or conversion : show line 1 in the form | +16,496 | $1.43 | $23,589 | 236,811 | D |
| 2024-08-19 | Sale : show line 2 in the form | −16,496 | $2.96 | $48,883 | 220,315 | D |
| Open-market sales · 16,496 sh · avg $2.96 · $48,883 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-19 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −16,496 | 0 | D |
Loading xslF345X05/ownership.xml…